Who is sponsoring NCT05151770?

NCT05151770 is sponsored by M-DT1.

What drugs are being tested in NCT05151770?

Interventions in NCT05151770: Measure of glycemia levels and comparison to algorithm predictions.

What condition does NCT05151770 study?

NCT05151770 studies Type I Diabetes.

Is NCT05151770 still recruiting?

NCT05151770 is currently completed. Last updated 15 March 2023.

Last reviewed 2023-03-15 · How we verify

NCT05151770: EGHYA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Type 1 Diabetic Post Prandial Glycemia Evaluation Using an Algorithm

Completed Last updated 15 March 2023

What this trial tests

trial testing Measure of glycemia levels and comparison to algorithm predictions in Type I Diabetes in 40 participants. Completed in 30 December 2022.

Timeline

30 December 2021

Primary endpoint
2 May 2022

30 December 2022

Quick facts

Lead sponsor	M-DT1
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	30 December 2021
Primary completion	2 May 2022
Estimated completion	30 December 2022
Sites	2 locations across France

Drugs / interventions tested

Measure of glycemia levels and comparison to algorithm predictions

Conditions studied

Type I Diabetes — all drugs for Type I Diabetes →

Sponsor

M-DT1

Who can join

18 and older, any sex, with Type I Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to demonstrate the efficacy of an algorithm to anticipate the post prandial glycemic profile in type I diabetic patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type I Diabetes

Currently open trials in the same condition.

NCT06964087 — Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05151770 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by M-DT1
Last refreshed: 15 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05151770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing